Shorla Pharma - Crunchbase Company Profile & Funding

Q: Where is Shorla Pharma's headquarters?

Shorla Pharma is located in Clonmel, Tipperary, Ireland.

Q: Who invested in Shorla Pharma?

Shorla Pharma has 3 investors including Enterprise Ireland And Seroba Life Sciences.

Q: When was the last funding round for Shorla Pharma?

Shorla Pharma closed its last funding round on obfuscated from a Series B round.

Q: How much funding has Shorla Pharma raised to date?

Shorla Pharma has raised obfuscated.

Overview

Shorla Pharma

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About Shorla Pharma

CB Rank

74684

Shorla Pharma is an Irish specialty pharmaceutical company.

Founded

obfuscation

Private

Series B

Clonmel, Tipperary, Ireland

11-50

www.shorlapharma.com/

Biotechnology

Pharmaceutical

Funding Rounds

Series B

OBF

obfuscation

Series A

OBF

obfuscation

Key People

Orlaith Ryan: Chief Technical Officer
Sharon Cunningham: CEO & Co-Founder

Details

Legal Name

Shorla Pharma Ltd

Also Known As

Shorla Oncology

Operating Status

Active

Company Type

For Profit

Founders

Orlaith Ryan, Sharon Cunningham

About the Company

Shorla Pharma is an Irish specialty pharmaceutical company. It is growing portfolio brings accessible, affordable and life-saving treatments to patients, delivering a major contribution to patient care and providing a significant clinical impact.

Contact Email

info@shorlapharma.com

Predictions & Insights

Growth Insight

See this Growth Insight

Shorla Pharma is

Lorem

to be growing

Top Contributing Factors

Recently Raised Funding

Growth Prediction

See this Growth Prediction

Top Contributing Factors

Key Employee Changes

Products & Services

Nelarabine Injection

A generic formulation of nelarabine used to treat T-cell acute lymphoblastic leukemia (T-ALL) and T-cell lymphoblastic lymphoma (T-LBL) in patients whose disease has not responded to or has relapsed following treatment with at least two chemotherapy regimens.

Jylamvo

An oral methotrexate solution indicated for adults with acute lymphoblastic leukemia (ALL), mycosis fungoides, relapsed or refractory non-Hodgkin lymphoma, rheumatoid arthritis, and severe psoriasis.

Research & Development

Shorla Pharma is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

...

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series B - Shorla Pharma	3	obfuscated obfuscation	Kurma Partners	Series B
obfuscated obfuscation	Series B - Shorla Pharma	3	obfuscated obfuscation	Kurma Partners	Series B
obfuscated obfuscation	Series B - Shorla Pharma	3	obfuscated obfuscation	Kurma Partners	Series B
obfuscated obfuscation	Series B - Shorla Pharma	3	obfuscated obfuscation	Kurma Partners	Series B
obfuscated obfuscation	Series B - Shorla Pharma	3	obfuscated obfuscation	Kurma Partners	Series B

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series B - Shorla Pharma	3	obfuscated obfuscation	Kurma Partners	Series B
obfuscated obfuscation	Series B - Shorla Pharma	3	obfuscated obfuscation	Kurma Partners	Series B
obfuscated obfuscation	Series B - Shorla Pharma	3	obfuscated obfuscation	Kurma Partners	Series B
obfuscated obfuscation	Series B - Shorla Pharma	3	obfuscated obfuscation	Kurma Partners	Series B
obfuscated obfuscation	Series B - Shorla Pharma	3	obfuscated obfuscation	Kurma Partners	Series B

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
Enterprise Ireland	—	Series B - Shorla Pharma	—
Enterprise Ireland	—	Series B - Shorla Pharma	—
Enterprise Ireland	—	Series B - Shorla Pharma	—
Enterprise Ireland	—	Series B - Shorla Pharma	—
Enterprise Ireland	—	Series B - Shorla Pharma	—